Diseases, Conditions, Syndromes

High doses of antiviral drug may be effective against Ebola

High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study published this week in PLOS Medicine by Jeremie Guedj of INSERM, France, and colleagues.

Diseases, Conditions, Syndromes

Ebola virus infects reproductive organs in monkeys

Ebola virus can infect the reproductive organs of male and female macaques, according to a study published in The American Journal of Pathology, suggesting that humans could be similarly infected. Prior studies of survivors ...

Diseases, Conditions, Syndromes

Research team unlocks secrets of Ebola

In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Diseases, Conditions, Syndromes

Experimental Ebola vaccines elicit year-long immune response

Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...

Diseases, Conditions, Syndromes

Ebola vaccine tests hailed a success

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

page 8 from 28